Cochrane Abstracts
Immunotherapy for metastatic renal cell carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunotherapy for Metastatic Renal Cell Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436393/all/Immunotherapy_for_metastatic_renal_cell_carcinoma.
Immunotherapy for metastatic renal cell carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436393/all/Immunotherapy_for_metastatic_renal_cell_carcinoma. Accessed November 22, 2024.
Immunotherapy for metastatic renal cell carcinoma. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436393/all/Immunotherapy_for_metastatic_renal_cell_carcinoma
Immunotherapy for Metastatic Renal Cell Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436393/all/Immunotherapy_for_metastatic_renal_cell_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunotherapy for metastatic renal cell carcinoma
ID - 436393
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436393/all/Immunotherapy_for_metastatic_renal_cell_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
